Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000497882 | SCV000579516 | likely pathogenic | Catecholaminergic polymorphic ventricular tachycardia 2 | 2017-02-09 | criteria provided, single submitter | clinical testing | ACMG score likely pathogenic |
Labcorp Genetics |
RCV002527048 | SCV002151140 | pathogenic | Catecholaminergic polymorphic ventricular tachycardia 1 | 2022-09-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp261*) in the CASQ2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CASQ2 are known to be pathogenic (PMID: 12386154). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 427947). This premature translational stop signal has been observed in individual(s) with catecholaminergic polymorphic ventricular tachycardia (PMID: 32693635). This variant is present in population databases (rs776874142, gnomAD 0.004%). |
Genome- |
RCV000497882 | SCV004050808 | likely pathogenic | Catecholaminergic polymorphic ventricular tachycardia 2 | 2023-04-11 | criteria provided, single submitter | clinical testing |